Angeliq (Drospirenone + Estradiol coated Tablets)

Bayer Pharma AG

Revision date : 2014-03-17

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 3

General Information

Revision date

2014-03-17

Product name

Angeliq (Drospirenone + Estradiol coated Tablets)

1.2.1 Relevant identified uses

unfinished drug mixture

Emergency telephone

+49 (0) 214 30 99300 (Sicherheitszentrale Bayer

Icons in SDS

GHS08

Company Information

company name

Bayer Pharma AG

e-mail address of the competent person responsible for the Safety Data Sheet

msds@bayerhealthcare.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H351, H360FD, H362, H412

Hazard statements

Code

Statements

H351

Suspected of causing cancer

Section 2

2.1 Classification of the substance or mixture

GHS-Classification (according to EC 1272/2008): Carcinogenicity, Category 2 (H351) Reproductive toxicity, Category 1A (H360FD) Effects on or via lactation (H362) Hazardous to the aquatic environment, Category 3 (H412) (67/548/EEC, 1999/45/EC) Carcinogenic Category 3 Toxic to Reproduction Category 1 Toxic to Reproduction Category 2 Dangerous for the environment Limited evidence of a carcinogenic effect. May impair fertility. May cause harm to the unborn child. May cause harm to breastfed babies. Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

2.2 Label elements

GHS-Labelling (according to EC 1272/2008): Danger

Hazard statements

H351 Suspected of causing cancer. H360FD May damage fertility. May damage the unborn child. H362 May cause harm to breast-fed children. H412 Harmful to aquatic life with long lasting effects.

Prevention

P260 Do not breathe dust or mist. P263 Avoid contact during pregnancy/ while nursing. P273 Avoid release to the environment. P281 Use personal protective equipment as required.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Hazardous Ingredients

67392-87-4 Drospirenon 35380-71-3 Estradiol-Hemihydrate Labelling according to EC Directives: Labelling in accordance with directive 1999/45/EC (preparations) and its amendments and adaptations 67392-87-4 Drospirenon 35380-71-3 Estradiol-Hemihydrate

R-phrase(s)

R60 May impair fertility. R61 May cause harm to the unborn child. R40 Limited evidence of a carcinogenic effect. R52/53 Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. R64 May cause harm to breastfed babies.

S-phrase(s)

S53 Avoid exposure - obtain special instructions before use. S22 Do not breathe dust. S35 This material and its container must be disposed of in a safe way. S36/37 Wear suitable protective clothing and gloves. S61 Avoid release to the environment. Refer to special instructions/ Safety data sheets.

Other hazards which do not result in classification

None known.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.